Factors Associated With Age Disparities Among Cancer Clinical Trial ParticipantsEthan B. Ludmir, Clifton D. Fuller, Jacob Mandel et al.|JAMA Oncology|2019Cited by 229
Tucatinib and Trastuzumab for Previously Treated Human Epidermal Growth Factor Receptor 2–Positive Metastatic Biliary Tract Cancer (SGNTUC-019): A Phase II Basket StudyYoshiaki Nakamura, Tanios Bekaii‐Saab, Nobumasa Mizuno et al.|Journal of Clinical Oncology|2023Cited by 100
Analysis of Cell-Free DNA from 32,989 Advanced Cancers Reveals Novel Co-occurring Activating <i>RET</i> Alterations and Oncogenic Signaling Pathway AberrationsThereasa A. Rich, Oliver Gautschi, Karen L. Reckamp et al.|Clinical Cancer Research|2019Cited by 91